Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival.

MLA

Manitz, Juliane, et al. “Comparison of Tumor Assessments Using RECIST 1.1 and IrRECIST, and Association with Overall Survival.” Journal for Immunotherapy of Cancer, vol. 10, no. 2, Feb. 2022. EBSCOhost, https://doi.org/10.1136/jitc-2021-003302.

APA

Manitz, J., D’Angelo, S. P., Apolo, A. B., Eggleton, S. P., Bajars, M., Bohnsack, O., & Gulley, J. L. (2022). Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival. Journal for Immunotherapy of Cancer, 10(2). https://doi.org/10.1136/jitc-2021-003302

Chicago

Manitz, Juliane, Sandra P D’Angelo, Andrea B Apolo, S Peter Eggleton, Marcis Bajars, Oliver Bohnsack, and James L Gulley. 2022. “Comparison of Tumor Assessments Using RECIST 1.1 and IrRECIST, and Association with Overall Survival.” Journal for Immunotherapy of Cancer 10 (2). doi:10.1136/jitc-2021-003302.